SELLAS Life Sciences is rated Hold, with a $9.25 price target, as current valuation already reflects high REGAL trial success ...

Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership for LabVantage.

Caris Life Sciences' Q2 featured accelerating clinical volumes, 68% gross margin, and strong early traction for Caris Detect.

Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...

As costs and regulatory pressures rise and educated patients clamor for personalized treatment, digital innovations will inexorably alter the life sciences landscape. Michael Townsend, research ...

A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...

CND Life Sciences, Inc. (CND), a medical technology company that advances neurodiagnostic tests and associated biomarker ...

BioAlberta is honoured to announce the recipients of the 2026 Achievement Awards at the Health and Life Sciences Showcase and Awards Dinner in Calgary on September 24 th, 2026. This year’s award ...

Plus: Billionaires push psychedelic treatments; investor Agora makes first deal ...

The companies that successfully raise money increasingly aren’t just those with the best research or technology. They are ...

Anthropic's new Life Sciences Verification Program gives qualifying organizations gated access to its Mythos 5.1 model for ...

Sai Life Sciences Ltd is quoting at Rs 1617, up 1.03% on the day as on 12:49 IST on the NSE. The stock is up 84.95% in last one year as compared to a 7.1% gain in NIFTY and a 20.91% gain in the Nifty ...